These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 24048171)
1. Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity. Da Costa Dias B; Jovanovic K; Gonsalves D; Moodley K; Reusch U; Knackmuss S; Penny C; Weinberg MS; Little M; Weiss SF Sci Rep; 2013; 3():2702. PubMed ID: 24048171 [TBL] [Abstract][Full Text] [Related]
2. Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease. Jovanovic K; Gonsalves D; Da Costa Dias B; Moodley K; Reusch U; Knackmuss S; Penny C; Weinberg MS; Little M; Weiss SF Sci Rep; 2013; 3():2699. PubMed ID: 24048412 [TBL] [Abstract][Full Text] [Related]
3. LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease. Pinnock EC; Jovanovic K; Pinto MG; Ferreira E; Dias Bda C; Penny C; Knackmuss S; Reusch U; Little M; Schatzl HM; Weiss SF J Alzheimers Dis; 2016; 49(3):645-57. PubMed ID: 26484914 [TBL] [Abstract][Full Text] [Related]
4. The 37kDa/67kDa laminin receptor acts as a receptor for Aβ42 internalization. Da Costa Dias B; Jovanovic K; Gonsalves D; Moodley K; Reusch U; Knackmuss S; Weinberg MS; Little M; Weiss SF Sci Rep; 2014 Jul; 4():5556. PubMed ID: 24990253 [TBL] [Abstract][Full Text] [Related]
5. Anti-LRP/LR-specific antibody IgG1-iS18 impedes adhesion and invasion of pancreatic cancer and neuroblastoma cells. Rebelo TM; Chetty CJ; Ferreira E; Weiss SF BMC Cancer; 2016 Nov; 16(1):917. PubMed ID: 27884119 [TBL] [Abstract][Full Text] [Related]
6. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor. Zuber C; Knackmuss S; Zemora G; Reusch U; Vlasova E; Diehl D; Mick V; Hoffmann K; Nikles D; Fröhlich T; Arnold GJ; Brenig B; Wolf E; Lahm H; Little M; Weiss S J Mol Biol; 2008 May; 378(3):530-9. PubMed ID: 18387633 [TBL] [Abstract][Full Text] [Related]
10. IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells. Munien C; Rebelo TM; Ferreira E; Weiss SF Exp Cell Res; 2017 Feb; 351(2):135-141. PubMed ID: 28118986 [TBL] [Abstract][Full Text] [Related]
11. Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity. Naidoo K; Malindisa ST; Otgaar TC; Bernert M; Da Costa Dias B; Ferreira E; Reusch U; Knackmuss S; Little M; Weiss SF; Letsolo BT PLoS One; 2015; 10(11):e0141618. PubMed ID: 26545108 [TBL] [Abstract][Full Text] [Related]
12. Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells. Chetty C; Khumalo T; Da Costa Dias B; Reusch U; Knackmuss S; Little M; Weiss SF PLoS One; 2014; 9(5):e96268. PubMed ID: 24798101 [TBL] [Abstract][Full Text] [Related]
13. siRNA - Mediated LRP/LR knock-down reduces cellular viability of malignant melanoma cells through the activation of apoptotic caspases. Rebelo TM; Vania L; Ferreira E; Weiss SFT Exp Cell Res; 2018 Jul; 368(1):1-12. PubMed ID: 29653110 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells. Bignoux MJ; Otgaar TC; Bernert M; Weiss SFT; Ferreira E FEBS Open Bio; 2023 Feb; 13(2):323-340. PubMed ID: 36579897 [TBL] [Abstract][Full Text] [Related]
16. Anti-LRP/LR-specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells. Omar A; Reusch U; Knackmuss S; Little M; Weiss SF J Mol Biol; 2012 May; 419(1-2):102-9. PubMed ID: 22391421 [TBL] [Abstract][Full Text] [Related]
17. Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18. Khumalo T; Reusch U; Knackmuss S; Little M; Veale RB; Weiss SF PLoS One; 2013; 8(6):e66297. PubMed ID: 23823499 [TBL] [Abstract][Full Text] [Related]